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ABSTRACT Hypoxia-induced muscle wasting is a
phenomenon often described with prolonged stays at
high altitude, which has been attributed to altered
protein metabolism. We hypothesized that acute nor-
mobaric hypoxia would induce a negative net protein
balance by repressing anabolic and activating proteo-
lytic signaling pathways at rest and postexercise and
that those changes could be partially genetically deter-
mined. Eleven monozygotic twins participated in an
experimental trial in normoxia and hypoxia (10.7%
O2). Muscle biopsy samples were obtained before and
after a 20-min moderate cycling exercise. In hypoxia at
rest, autophagic flux was increased, as indicated by an
increased microtubule-associated protein 1 light chain
3 type II/I (LC3-II/I) ratio (25%) and LC3-II expres-
sion (60%) and decreased p62/SQSTM1 expression
(25%; P<0.05), whereas exercise reversed those
changes to a level similar to that with normoxia except
for p62/SQSTM1, which was further decreased (P<0.05).
Hypoxia also increased Bnip3 (34%) and MAFbx
(18%) mRNA levels as well as REDD1 expression
(439%) and AMP-activated protein kinase phosphor-
ylation (22%; P<0.05). Among the molecular re-
sponses to hypoxia and/or exercise, high monozygotic
similarity was found for REDD1, LC3-II, and LC3-II/I
(P<0.05). Our results indicate that environmental hyp-
oxia modulates protein metabolism at rest and after
moderate exercise by primarily increasing markers of
protein breakdown and, more specifically, markers of
the autophagy-lysosomal system, with a modest genetic
contribution.—Masschelein, E., Van Thienen, R.,
D’Hulst, G., Hespel, P., Thomis, M., Deldicque, L.
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Throughout life, most individuals experience episodes
of tissue hypoxia, i.e., a state of lowered oxygen tension in
tissues, and need to adapt to this environmental or
pathological state. Tissue hypoxia can occur in healthy
humans during a stay at high altitude (1), but various
pathological conditions, such as chronic obstructive pul-
monary disease (2), obstructive sleep apnea (3), and
anemia (4), are also associated with tissue hypoxia. What-
ever the origin of the hypoxia, physiological adaptations
need to come into play to mitigate the reduced oxygen
availability. For example, long-lasting hypoxia often leads
to a negative regulation of protein metabolism and a loss
of muscle mass. Epidemiological studies performed in
natives of Tibetan, Ethiopian, and Andean highlands
reported major population-specific differences in adap-
tive mechanisms to protect against hypoxia in their habi-
tat (5–8). Those observations suggest that genetic variants
are probably involved in the physiological adaptations to
hypoxia. Although variability in cardiorespiratory re-
sponses to hypoxia has shown a clear genetic component
(9, 10), little is known about the individual variability in
muscle wasting responses related to hypoxia and their
underlying regulatory pathways. Furthermore, the role of
genetic variation in this variability has not been studied
before.
The majority of the work dealing with the regulation
of protein metabolism by hypoxia comes from in vitro
studies. In vitro, it is commonly assumed that hypoxic
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conditions inhibit muscle protein synthesis (11). The
latter is mainly controlled by the mammalian target of
rapamycin complex 1 (mTORC1) pathway, which phos-
phorylates and activates 2 key regulators in the initia-
tion step, the ribosomal protein S6 kinase 1 (S6K1) and
the eukaryotic initiation factor 4E-binding protein 1
(4E-BP1), a repressor of the cap-binding eukaryotic
initiation factor 4F (eIF4F) complex. During hypoxia,
mTORC1 has been found to be inhibited by AMP-
activated protein kinase (AMPK; ref. 12) and by the
protein called regulated in development and DNA
damage responses 1 (REDD1; ref. 13).
Unfortunately, those in vitro studies have mainly
focused on the regulation of protein synthesis by hyp-
oxia, whereas net protein balance is also determined by
protein degradation. Recent animal studies give further
insight into the anabolic and catabolic processes in
response to hypoxic conditions in vivo (14–17). Al-
though not corroborated by everyone (17), hypoxia
seems to activate the ubiquitin-proteasome pathway as
well as calpains (14, 15). The mRNA levels of the 2
muscle-specific ligases muscle ring finger protein-1
(MuRF-1) and muscle atrophy F box (MAFbx; ref. 15),
which are up-regulated under conditions of muscle
atrophy (18), and the levels of ubiquitinated proteins
(14) are increased after several days of exposure to
hypoxia in rat skeletal muscle.
Besides the ubiquitin-proteasome pathway and cal-
pains, attention to a third proteolytic system, i.e., the
autophagy-lysosomal pathway, is increasing (19, 20). In
brief, in this system, double membrane vesicles that
engulf portions of the cytoplasm, organelles, glycogen,
and protein aggregates are generated. The autophago-
somes formed bind to lysosomes, forming autolyso-
somes for degradation of their contents by lysosomal
hydrolases. Autophagosome formation is under the
control of some autophagy-related genes (ATGs) such
as ATG5, ATG12, and ATG8 also known as microtu-
bule-associated protein 1 light chain 3 (LC3; ref. 20).
More recently, p62/sequestosome 1 (p62/SQSTM1)
has been found to play a key role in delivering ubiqui-
tinated proteins to autophagosomes (21). The ubiqui-
tin-proteasome pathway and autophagy-lysosomal path-
way are under the control of, among others, the
forkhead box protein O (FoxO) transcription factors,
which themselves are regulated by protein kinase B
(PKB). Whereas autophagy clearly plays an important
role in skeletal muscle degradation, this process has
only been investigated indirectly in skeletal muscle
during hypoxia via lipofuscin release, which reflects
membrane damage (22).
In a study of the regulation of muscle mass by
environmental hypoxia, many confounding factors
have to be taken into account. Long-term hypoxia at
extreme altitude is known to reduce appetite and
energy intake (23) and to disturb the sleep cycle (24),
thereby indirectly favoring a catabolic state. It is thus
difficult to determine whether the reduction in muscle
mass observed after long-term exposure to hypoxia is
due to hypoxia per se or to the aforementioned con-
founding factors. By simulating high altitude in a
hypoxic facility, we were able to standardize the nutri-
tional status of the subjects. To the best of our knowl-
edge, D’Hulst et al. (25) from our laboratory are the
only researchers to have systematically studied the
effect of hypoxia on anabolic and catabolic signaling
pathways in human skeletal muscle. Whereas protein
degradation was only marginally enhanced, PKB and
S6K1 phosphorylations were higher in skeletal muscles
of subjects resting for 4 h in hypoxia, which contrasted
with previously published reports (11–13, 17). How-
ever, autophagy was not assessed in this previous study,
and how skeletal muscle protein metabolism is regu-
lated by hypoxia after exercise in human remains
unknown. Against this background, we investigated the
effect of acute environmental hypoxia on markers of
muscle protein synthesis and protein breakdown before
and after a submaximal cycling session. Based on the
majority of published data, we hypothesized that acute
normobaric hypoxia would induce a negative net pro-
tein balance by repressing anabolic and activating
proteolytic signaling pathways at rest and postexercise.
In addition, the unique study sample of monozygotic
(MZ) twins enabled us to estimate the genetic determi-
nation of protein and gene expression in response to
hypoxia and/or exercise.
MATERIALS AND METHODS
Subjects
The data presented here are original except for arterial O2
saturation (%SpO2) and are part of a larger study in which 13
MZ twin pairs were enrolled. Of the 13 twins, 11 allowed
muscle biopsy samples to be collected and are included in the
present article [n22; age, 24.40.8 yr; body weight,
75.91.7 kg; maximal oxygen consumption (Vo2max),
55.32.1 ml O2/kg/min in normoxia and 33.51.3 ml
O2/kg/min in hypoxia]. Data for %SpO2 are presented
elsewhere (unpublished results) but have been recalculated
according to the number of twins used in the present report.
Inclusion criteria were nonsmoking, no history of cardiovas-
cular or respiratory disease, similar fitness levels within twins,
and no residence at altitude1500 m during 6 mo before the
study. The study was approved by the local ethics committee
and was performed in accordance with the Declaration of
Helsinki. Subjects gave written consent after medical exami-
nation and being informed of all experimental procedures.
Monozygosity was confirmed via 8 polymorphic markers
[chromosome (chr) 13, GATA30H01 and GATA85D03; chr
18, GATA2E06, GATA64H04, and GATA88A12; and chr 21,
GATA163G03, GATA24H09, and GATA71H10]. Twins were
instructed to maintain habitual diet and physical activity levels
during the study and to omit exercise for 24 h before each
experimental day.
Study design
Subjects participated in 2 experimental days in a normobaric
hypoxic facility at 20°C and 50% relative humidity (Sporting
Edge, Sherfield on Loddon, UK) with a 2-wk washout period
in between. The first experimental trial was in normoxia
conditions (NOR; Fio220.9%) and the second in hypoxia
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conditions (HYP; Fio210.7%). The NOR experiment was
done first to exclude possible “memory” effects due to
preceding hypoxic exposure. Breakfast (700 kcal from 84%
carbohydrates, 9% fat, and 7% protein) and later meals and
snacks (1880 kcal from 76% carbohydrates, 12% fat, and 12%
protein) and drinks (500 ml of water/2 h) on the experimen-
tal days were standardized. On each day, twins reported to the
hypoxic facility at 8:00 am and were installed in a separate
compartment to keep them ignorant about their brothers.
They first rested for 5 h in a chair in either normoxia (NOR
group) or while Fio2 was gradually decreased to 10.7% (HYP
group), and they then stayed for 3 h in the target Fio2 for the
experimental protocol. A blood sample was taken preexercise
(pre-ex) from an antecubital vein, and a biopsy sample, with
the needle pointing proximally, was taken from the left
musculus vastus lateralis under local anesthesia (1 ml of
lidocaine) through a 5-mm incision in the skin. Subjects then
performed a 20-min submaximal constant-load (1.2 W/kg)
exercise bout on a cycle ergometer (Cyclus II; Avantronic,
Leipzig, Germany). The intensity of the exercise corre-
sponded to 50.7  2.3% of Vo2max in normoxia vs. 81.4 
3.2% of Vo2max in hypoxia. The load and the duration of the
exercise were chosen after preliminary experiments had
shown that 1.2 W/kg for 20 min in similar subjects corre-
sponded to near-maximal exercise tolerance at Fio2 of 10.7%.
A constant-load protocol was chosen to simulate an ascent to
a summit during which climbers have to be roped together
and move at the same pace. The same absolute intensity,
instead of the same relative intensity, between normoxia and
hypoxia was chosen because we were interested in knowing
whether the response to a given absolute exercise intensity
would be different in hypoxia than in normoxia. Immediately
postexercise (post-ex), another blood sample and muscle
biopsy sample (through the same incision as the pre-ex biopsy
sample, but with the needle pointing distally) were taken.
Venous blood samples were immediately centrifuged, and
plasma was separated to be stored at 20°C for later analysis
of insulin. Muscle samples were quickly frozen in liquid
nitrogen and stored at 80°C until further analysis.
During each experimental session, %SpO2 was measured
continuously by a pulse oximeter (Nellcor N-600x; Covidien,
St. Louis, MO, USA) with a sensor placed 2 cm above the
right eyebrow. Local tissue oxygenation status of the right
musculus vastus lateralis was continuously measured (1 Hz)
by near-infrared spectroscopy (NIRO-200; Hamamatsu Pho-
tonics, Hamamatsu, Japan) via the tissue oxygenation index
(TOI), which is a valid parameter to assess the fraction of
O2-saturated tissue hemoglobin and myoglobin content (26).
The probe was attached on the belly, in parallel with the long
axis of the muscle.
Plasma insulin
The plasma insulin concentration was determined by ELISA
using the ultrasensitive insulin kit from Mercodia (Uppsala,
Sweden). In brief, plasma samples (25 l) were added onto a
mouse monoclonal anti-insulin-coated plate with enzyme
conjugate solution (100 l) and incubated for 1 h at room
temperature. After 5 washes, tetramethylbenzidine (TMB)
substrate (200 l) was added. After 5 min of incubation with
TMB, 50 l of a stop solution containing 0.5 M H2SO4 was
added, and absorbance was read at 450 nm.
Western blot
Details of the immunoblotting procedures were described
previously (27). In brief, frozen muscle tissue (20 mg) was
homogenized 3 times for 5 s each with a Polytron mixer
(Polytron Technologies, Taoyuan City, Taiwan) in ice-cold
buffer [1:10, w/v; 50 mM Tris-HCl, pH 7.0; 270 mM sucrose;
5 mM EGTA; 1 mM EDTA; 1 mM sodium orthovanadate; 50
mM glycerophosphate; 5 mM sodium pyrophosphate; 50 mM
sodium fluoride; 1 mM dithiothreitol; 0.1% Triton X-100; and
a complete protease inhibitor tablet (Roche Applied Science,
Vilvoorde, Belgium)]. Homogenates were then centrifuged at
10,000 g for 10 min at 4°C. The supernatant was collected and
immediately stored at 80°C. The protein concentration was
measured using a DC protein assay kit (Bio-Rad Laboratories,
Nazareth, Belgium). Proteins (3080 g) were separated by
SDS-PAGE (812% gels) and transferred to polyvinylidene
difluoride membranes. Subsequently, membranes were blocked
with 5% nonfat milk for 1 h and then incubated overnight
(4°C) with the following antibodies (1:1000): phospho-Akt/
PKB Ser473, Akt/PKB pan, ATG12, phospho-5=-AMP-activated
protein kinase (AMPK) Thr172, total AMPK, total eukaryotic
elongation factor 2 (eEF2), phospho-S6K1 Thr389, total S6K1,
phospho-4E-BP1 Thr37/46, total 4E-BP1, p-FoxO1 Thr24/
FoxO3a Thr32, total FoxO3a, and LC3 (Cell Signaling, Le-
iden, The Netherlands); REDD1 (Bio-Connect, Huissen, The
Netherlands); p62/SQSTM1 (Progen; Biotechnik, Heidel-
berg, Germany); MAFbx (Emelca Bioscience, Breda, The
Netherlands); and MuRF-1 (Santa Cruz Biotechnology,
Heidelberg, Germany). Horseradish peroxidase-conjugated
anti-rabbit (1:5000) and anti-guinea pig (1:5000) secondary
antibodies (Sigma-Aldrich, Bornem, Belgium) were used for
chemiluminescent detection of proteins. Membranes were
scanned and quantified with GeneSnap and Gene Tools
software (Syngene, Cambridge, UK), respectively. Then,
membranes were stripped and reprobed with the antibody for
the total form of the respective protein to ascertain the
relative amount of the phosphorylated protein compared
with the total form throughout the whole experiment. The
results are presented as the ratio protein of interest/eEF2 or
as the ratio phosphorylated/total forms of the proteins when
the phosphorylation status of the protein was measured. All
values from the respective condition were reported to the
mean value of the first sample (pre-ex) in NOR.
RNA extraction and reverse transcription
The method used for reverse transcription is described in detail
elsewhere (28, 29). In brief, total RNA was extracted using
TRIzol (Invitrogen, Vilvoorde, Belgium) from 2025 mg of
frozen muscle tissue. Total RNA was extracted in 19 subjects
because of the lack of material in 3 individuals. RNA quality and
quantity were assessed by spectrophotometry with a NanoDrop
(Thermo Scientific, Erembodegem, Belgium). Then 1 g of
RNA was reverse-transcribed using a High-Capacity cDNA Re-
verse Transcription kit (Applied Biosystems, Gent, Belgium)
according to the manufacturer’s instructions.
Real-time quantitative PCR analysis
A SYBR Green-based master mix (Applied Biosystems) was used
for real-time PCR analyses using the ABI PRISM 7300 system
(Applied Biosystems). Real-time PCR primers were designed for
human MuRF-1, MAFbx, Bcl-2/adenovirus E1B 19-kDa protein-
interacting protein 3 (Bnip3), proliferating cell nuclear antigen
(PCNA), and myostatin (MSTN; Table 1). Thermal cycling con-
ditions consisted of 40 3-step cycles including denaturation for
30 s at 95°C, annealing for 30 s at 58°C, and extension for 30 s
at 72°C. All reactions were performed in triplicate. To compen-
sate for variations in input RNA amounts and efficiency of
reverse transcription, glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) and ribosomal protein L4 (RPL4) mRNA were
quantified, and results were normalized to these values. These
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genes were chosen out of 3 normalization genes using the
GeNorm applet according to the guidelines and theoretical
framework described elsewhere (30). All values from the respec-
tive condition were reported to the mean value of the first
sample (pre-ex) in NOR.
Statistical analysis
A 2-way repeated-measures analysis of variance (ANOVA) was
used to assess the statistical significance of differences between
mean values over time and between conditions (Systat Software,
San Jose, CA, USA). When appropriate, a Bonferroni t test was
used as a post hoc test. In addition, the correlated observations at
the level of the twins, together with the individual repeated
measures of the oxygen level conditions and exercise response
(time) were also analyzed using a multilevel mixed-model ap-
proach (random effects for time level nested in condition level,
nested in twin level; SAS 9.3; SAS Institute, Cary, NC, USA).
Because the multilevel mixed-model approach gave the same
significant results as the ANOVA, it was chosen to present all
data according to the results of the 2-way repeated-measures
ANOVA analyses. When the latter analyses revealed a significant
difference in protein or mRNA expression, the genetic influ-
ence was determined by 2-way repeated-measures ANOVA on
one factor, with the twins nested in pairs, and by intraclass
correlation coefficients (ICCs; ref. 31; SAS Enterprise Guide 4.3,
SAS Institute). F ratios thus obtained represent the ratio of
between-pair over within-pair variability in the induced re-
sponses, whereas ICCs provide a quantitative estimate of the
similarity within MZ twin pairs and an upper-limit estimate of the
genetic component in these responses (genotypehypoxia and
genotypeexercise interaction). A probability level of P  0.05
was considered statistically significant. All data are means sem.
RESULTS
Arterial and muscle tissue oxygenation status
Compared with exposure to NOR, exposure to HYP
caused a 22% decrease in %SpO2 pre-ex (P0.05) and
another 6% decrease post-ex (P0.05; Table 2). HYP-
induced changes in %SpO2 were accompanied by lower
TOI both pre-ex (5%, P0.05) and post-ex(9%,
P0.05). In NOR, exercise decreased muscle TOI
(6%, P0.05) without modifying %SpO2.
PKB/mTOR pathway
No significant differences were found between NOR
and HYP for PKB (Fig. 1A), S6K1 (Fig. 1B), and 4E-BP1
(Fig. 1C) phosphorylation and plasma insulin levels
(Fig. 1D) whether at rest or post-ex. Post-ex, phosphor-
ylation of PKB at Ser473 decreased by 35% in NOR
(P0.05) and 29% in HYP (P0.05; Fig. 1A). This
exercise-induced dephosphorylation was also observed
for PKB downstream targets, S6K1 at Thr389 (NOR:
51%, HYP: 47%, P0.05; Fig. 1B) and 4E-BP1 at
Thr37/46 (NOR: 15%, HYP: 19%, P0.05; Fig. 1C).
Furthermore, exercise reduced plasma insulin in both
NOR (46%, P0.05) and HYP (34%, P0.05; Fig.
1D). REDD1 and AMPK are known to inhibit the
mTOR pathway and to be up-regulated in hypoxia (32).
In HYP compared with NOR, phosphorylation of
AMPK at Thr172 (Fig. 1E) and REDD1 protein expres-
sion (Fig. 1F) were increased both pre-ex and post-ex.
In addition to those individual responses, the unique
study sample of MZ twins gave the opportunity to
estimate the genetic determination of protein and gene
expressions in response to hypoxia and/or exercise
(Table 3). In response to hypoxia, a large interindi-
vidual variability was found for 	REDD1 protein ex-
pression pre-ex (0.7- to 29.8-fold) and post-ex (0.2- to
44.7-fold). However, these expressions were not ran-
domly distributed and high similarities within twin pairs
were found, indicating a familial and most likely a
genetic influence. The response to hypoxia of each
twin pair for the expression of REDD1 pre-ex and
post-ex is presented in Fig. 1H, I, respectively. 	REDD1
was highly similar within twin pairs pre-ex (ICC0.87,
P0.05; Fig. 1H), with 6.5-fold higher variability be-
tween pairs than within pairs, and post-ex (ICC0.93,
P0.05; Fig. 1I), with 13.2-fold higher variability be-
tween pairs than within pairs.
TABLE 1. Primer sequences
Sequences
Primer Forward Reverse
MuRF-1 AAACAGGAGTGCTCCAGTCGG CGCCACCAGCATGGAGATACA
MAFbx CCCAAGGAAAGAGCAGTATGGAGA GGGTGAAAGTGAAACGGAGCA
Bnip3 CTGAAACAGATACCCATAGCATT CCGACTTGACCAATCCCA
PCNA ATCCTCAAGAAGGTGTTGGAGGCA ACGAGTCCATGCTCTGCAGGTTTA
MSTN CTACAACGGAAACAATCATTACCA GTTTCAGAGATCGGATTCCAGTAT
GAPDH CATGTTCGTCATGGGTGTGAACCA AGTGATGGCATGGACTGTGGTCAT
RPL4 ATACGCCATCTGTTCTGCCCT GCTTCCTTGGTCTTCTTGTAGCCT
TABLE 2. Effect of hypoxia on arterial O2 saturation and muscle
tissue oxygenation status pre-ex and post-ex
Parameter NOR HYP
%SpO2
Pre-ex 99.3  0.2 79.3  0.9*
Post-ex 97.6  0.3 70.6  0.7*,#
TOI (%)
Pre-ex 68.9  0.3 65.7  0.3*
Post-ex 64.2  0.3# 58.6  0.5*,#
Values are means  sem (n22) for %SpO2 and muscle TOI
pre-ex and post-ex in NOR and HYP groups. *P  0.05 vs. NOR;
#P  0.05 vs. pre-ex.
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Autophagy-related markers
The nonlipidated form of LC3 (LC3-I) was not modi-
fied at rest in HYP compared with NOR but was lowered
post-ex in HYP (17%, P0.05; Fig. 2A). Exercise had
no effect on LC3-I in NOR (Fig. 2A). The lipidated
form of LC3 (LC3-II) is used as a valuable marker of the
presence of autophagosomes in the cell (33). At rest,
LC3-II and the LC3-II/I ratio were increased in HYP
compared with NOR by 45% (P0.05) and 29% (P0.05),
respectively (Fig. 2B, C). However, this increase in HYP
at rest was entirely reversed post-ex because LC3-II and
LC3-II/I were decreased by 32% (P0.05) and 44%
(P0.05), respectively, reaching values similar to those
in NOR. The ATG5-conjugated form of ATG12
(cATG12) was not affected by any condition (Fig. 2D).
p62/SQSTM1 is another autophagy marker that is
Figure 1. Effect of environmental hypoxia and exercise on the PKB/mTOR pathway. AF) PKB (A), S6K1 (B), and 4E-BP1 (C)
phosphorylation, plasma insulin levels (D), AMPK phosphorylation (E), and REDD1 protein expression (F) pre-ex and post-ex
in NOR and HYP groups. G) Representative blots. Data are means  sem (n22). *P0.05 vs. NOR; #P  0.05 vs. pre-ex. H,
I) HYP-induced changes (	) in REDD1 protein expression pre-ex (H) and post-ex (I) are presented for 11 pairs of MZ twins.
Each point represents one pair of twins (twin A and twin B). ICCs and corresponding F ratios (between/within pairs variance)
are illustrated in the figure.
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involved in linking polyubiquitinated protein aggre-
gates to the autophagy machinery and is degraded by
the lysosome together with the aggregates. Therefore,
p62/SQSTM1 can be used as a marker of the au-
tophagic flux (34). In HYP compared with NOR, p62/
SQSTM1 was decreased pre-ex and post-ex by 25 and
15%, respectively (Fig. 2E). Furthermore, compared
with pre-ex levels, p62/SQSTM1 was decreased post-ex
in HYP (15%, P0.05) but not in NOR. mRNA
expression of Bnip3, a mitophagy-related gene (35),
was increased by 34% at rest in HYP compared with that
in NOR (P0.05) but returned to a level similar to that
in NOR post-ex (P0.05; Fig. 2F). As for REDD1, a high
similarity between twins was found in the response to
HYP at rest for LC3-II protein expression (Fig. 2H) and
in the response to exercise in HYP for the ratio
LC3-II/I (Fig. 2I). 	LC3-II was highly similar within
twin pairs pre-ex (ICC0.77, P0.05; Fig. 2H), with
3.3-fold higher variability between pairs than within
pairs. High MZ twin pair resemblance was also found
for 	LC3-II/I in the response to exercise in HYP
(ICC0.83, F ratio4.74, P0.05; Fig. 2I).
Ubiquitin-proteasome-related markers
MAFbx mRNA expression was increased by 18%
(P0.05; Fig. 3A) at rest in HYP compared with NOR
and returned to values similar to those in NOR post-ex
(P0.05). MuRF-1 mRNA expression did not change at
rest in HYP or post-ex (Fig. 3B). At the protein level,
MAFbx (Fig. 3C) and MuRF-1 (Fig. 3D) were not
modified by any condition. The transcription of MAFbx
and MuRF-1 is under the control of a family of tran-
scription factors called FoxO (36), among others. How-
ever, phosphorylation of FoxO1/3a at Thr24/32 was not
different in any condition (Fig. 3E).
Muscle growth markers
PCNA is a marker of DNA synthesis and satellite cell
proliferation (37). PCNA mRNA expression was not
modified at rest, whereas it was significantly in-
creased post-ex in HYP compared with that in NOR
(
32%, P0.05; Fig. 4A). A trend for high MZ twin
pair similarity was found in the response to exercise
in HYP (ICC0.72, F ratio2.52, P0.10; Table 3).
Exercise had no effect on PCNA mRNA expression in
NOR. MSTN, an inhibitor of muscle differentiation
and growth, was not affected by any condition.
DISCUSSION
Hypoxia-induced muscle wasting is a phenomenon
often described as a consequence of high altitude
TABLE 3. MZ twin resemblance for significant molecular adaptations to hypoxia and/or exercise
Effect of hypoxia Effect of exercise
Pre-ex NOR vs.
Pre-ex HYP
Post-ex NOR vs.
Post-ex HYP
Pre-ex NOR vs.
post-ex NOR
Pre-ex HYP vs.
post-ex HYP
Parameter ICC F ICC F ICC F ICC F
Protein expression
LC3-I 0.35 0.54
LC3-II 0.77* 3.30 0.62 1.66
LC3-II/I 0.71# 2.41 0.83* 4.74
cATG12
p62/SQSTM1 0.38 0.62 0.56 1.29 0.21 0.27
MAFbx 0.40 0.67 0.52 1.10
MuRF-1
REDD1 0.87* 6.59 0.93* 13.23
Phosphorylation
p-PKB Ser473 0.63 1.68 0.66 1.99
p-S6K1 Thr389 0.65 1.87 0.40 0.67
p-4E-BP1
Thr37/46
0.28 0.38 0.37 0.59
p-FoxO1/3
Thr24/32
p-AMPK Thr172 0.30 0.43 0.40 0.67
mRNA expression
Bnip3 0.38 0.62 0.25 0.34
MAFbx
MuRF-1
PCNA 0.72# 2.52
MSTN
ICCs and corresponding F ratios (between/within pairs variance) represent similarity within twin pairs for the response to hypoxia pre-ex
and post-ex and the response to exercise in NOR and HYP groups. Underscored results are presented in Figs. 1 and 2, where each twin pair
response is illustrated. A full report containing all ICCs can be found in Supplemental Table S1. n  11 twins for protein expression and
phosphorylation, and n  8 twins for mRNA expression. *P  0.05; #P  0.10.
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(38, 39) and several pathological conditions (40, 41);
however, the molecular mechanisms underlying the
loss of human skeletal mass are poorly understood.
Therefore, we designed a well-controlled study in our
normobaric hypoxic chamber to investigate anabolic
and catabolic signaling pathways in response to hyp-
oxia. We show for the first time that exposure to
environmental hypoxia increased LC3 lipidation and
decreased p62/SQSTM1 protein expression in skel-
etal muscle, which together indicate a higher rate of
autophagic initiation and degradation and thus
higher autophagic flux (42). Responses in LC3 lipi-
dation showed large individual differences with high
MZ twin similarity, which point to the role of under-
lying genetic variants to at least partially explain
these differences.
Figure 2. Effect of environmental hyp-
oxia and exercise on autophagy- and
mitophagy-related markers. AF) LC3-I
(A), LC3-II (B), LC3-II/I (C), cATG12
(D), and p62/SQSTM1 (E) protein expressions (n22) and Bnip3 mRNA expression (F; n19) pre-ex and post-ex in NOR
and HYP groups. G) Representative blots. Data are means  sem. *P  0.05 vs. NOR; #P  0.05 vs. pre-ex. H, I)
HYP-induced changes (	) in LC3-II protein expression at rest (H) and exercise-induced changes (	) in LC3-II/I ratio (I)
in HYP are presented for 11 pairs of MZ twins. Each point represents one pair of twins (twin A and twin B). ICCs and
corresponding F ratios (between/within pairs variance) are illustrated in the figure.
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Activation of autophagy by acute environmental
hypoxia
Until now, research has mainly focused on muscle
protein synthesis, and less is known about muscle
protein degradation in hypoxia, certainly in humans.
Two major proteolytic pathways control protein degra-
dation in skeletal muscle: the ubiquitin-proteasome
and the autophagy-lysosomal pathways (19). To the best
of our knowledge only one study evaluated the effect of
hypoxia on the autophagy-lysosomal pathway (22). In
that study, the volume density of lipofuscin was used as
a marker for mitochondria and lysosome membrane
damage. More lipofuscin was found in skeletal muscle
of climbers staying for 8 wk at5000 m. Whether other
markers of the autophagy-lysosomal pathway are mod-
ified under hypoxic conditions is not known, nor is the
effect of acute hypoxia.
The present study shows for the first time an increase
in protein markers of the autophagy-lysosomal pathway
in response to short-term environmental HYP in hu-
man skeletal muscle. Autophagosome formation is un-
der the control of ATG proteins, including the ATG12-
ATG5 complex and ATG8 or LC3. In the present study,
no alteration was found in cATG12; however, the
lipidated form of LC3, LC3-II, increased in hypoxia.
The conversion of cytosolic microtubule-associated pro-
Figure 3. Effect of environmental hypoxia and exercise on ubiquitin-proteasome-related markers. AE) MAFbx (A) and MuRF-1
(B) mRNA expressions (n19), MAFbx (C) and MuRF-1 (D) protein expressions, and FoxO1/3a phosphorylation (E; n22)
pre-ex and post-ex in NOR and HYP groups. F) Representative blots. Data are means  sem. *P  0.05 vs. NOR; #P  0.05 vs.
pre-ex.
Figure 4. Effect of environmental hypoxia and
exercise on muscle growth-related genes. A, B)
PCNA (A) and MSTN (B) mRNA expressions
pre-ex and post-ex in NOR and HYP groups.
Data are means  sem (n19). *P  0.05 vs.
NOR.
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tein I (LC3-I) to the autophagosomal membrane-asso-
ciated form (LC3-II), is a marker of autophagic activity,
whereas LC3-II alone is used as a valuable marker of the
presence of autophagosomes in the cell (33). We found
a large increase in LC3-II/I and LC3-II in response to
hypoxia, suggesting an increase in autophagic activity
and the presence of autophagosomes. However, this
conclusion has to be drawn with caution because an
increase in LC3 lipidation reflects increased autopha-
gosome formation due to either an increase in au-
tophagic activity or a reduced turnover of autophago-
somes (42). Indeed, during autophagy, the autophagosomes
fuse with lysosomes to form autolysosomes, and the
autophagosomal content is degraded by lysosomal hy-
drolases. At the same time, LC3 in the autolysosomal
lumen is degraded. Therefore, an increase in LC3 may
result from a reduced turnover of autophagosomes
rather than from an increased autophagic activity. To
get a better picture of the autophagic flux, p62/
SQSTM1 has to be determined together with LC3
expression. The p62/SQSTM1 protein serves as a link
between LC3 and ubiquitinated substrates to deliver
them selectively into the autophagosome (21). p62/
SQSTM1 is known to be degraded together with the
autophagosome content and can thus be used as a
marker of autophagic flux (34). In hypoxia, LC3-II and
LC3-II/I were increased concomitantly with decreased
p62/SQSTM1, indicating that the whole autophagic
flux was increased. Following exercise in hypoxia, a
decrease in LC3-I, LC3-II, and LC3-II/I as well as in
p62/SQSTM1 protein levels was found compared with
those under resting conditions in hypoxia, suggesting
that the autophagosomes formed before exercise were
degraded as a result of the endurance exercise (43).
Together with the increase in Bnip3 mRNA, an impor-
tant regulatory gene in autophagy and mitophagy (35,
44), our results suggest that autophagic activity in
human skeletal muscle is enhanced in hypoxia, and this
activity seems to be reduced by exercise, returning to a
level similar to that observed in normoxia.
Two studies in rat skeletal muscle indicated that the
ubiquitin-proteasome pathway may be responsible for
enhanced protein degradation in skeletal muscle under
acute and chronic hypoxia (14, 45). Furthermore,
Chaillou et al. (15) have shown that hypoxia transiently
impaired the overload-induced muscle hypertrophy,
partially due to up-regulation of MAFbx and MuRF-1
mRNA expression in rat skeletal muscle. In human
skeletal muscle, MuRF-1 mRNA expression increased,
whereas MAFbx decreased during acute exposure to
environmental hypoxia (25). A different regulation of
those 2 E3 ligases was found in the present study
because, during hypoxia, MAFbx mRNA increased at
rest and returned to levels similar to those in normoxia
after exercise, whereas MuRF-1 remained unchanged.
However, those modifications were not found at the
protein level, suggesting that in acute hypoxia, the
ubiquitin-proteasome pathway plays no major role in
human skeletal muscle.
In skeletal muscle, FoxO1 and FoxO3a have been
identified as critical transcription factors controlling
proteolysis. FoxOs stimulate protein degradation by
transcriptional activation of key genes from both the
ubiquitin-proteasome pathway and autophagy-lyso-
somal pathway (44, 46). The activity of FoxOs is
primarily regulated by their phosphorylation state
(47). In a catabolic state, phosphorylated FoxOs
translocate from the cytosol to the nucleus and bind
to target genes. We found no change in phosphory-
lation state for FoxOs, suggesting that the ubiquitin-
proteasome pathway and the autophagy-lysosomal
pathway are controlled through an alternative path-
way independent from FoxOs.
No alteration of the mTORC1 pathway by acute
environmental hypoxia
The main findings of the present study suggest that
hypoxia modulates protein metabolism primarily by
altering markers of protein breakdown, whereas ana-
bolic signaling is not preferentially altered in hypoxia.
These results are in contrast to earlier findings in our
laboratory (25), which show that hypoxia activates the
mTORC1 pathway in a way that is theoretically favor-
able for muscle protein accretion. However, the pur-
pose of that previous study was to investigate the
response to a meal while the subjects were sitting in a
hypoxic environment for 4 h. Compared with this
previous study in which the unique meal was taken in
normoxia, here food intake was spread over the 8-h
experimental trial. The mTORC1 pathway was up-
regulated in hypoxia, probably due to higher plasma
insulin levels (25), whereas in the present study, insulin
levels were not altered by hypoxia. No clear reason to
explain this difference in insulin concentrations was
found, but the nutritional pattern was different in both
studies, which could have elicited different insulin
regulation. In addition, it is possible that the gradual
decrease of Fio2 in the present study (from 20.9 to
10.7% inspired O2 over 5 h), compared with the more
stressful direct exposure to the targeted Fio2 in D’Hulst
et al. (25; 11% inspired O2), could have induced a
smaller catecholamine response or a response that did
not elicit any modification in insulin production (48).
However, a lack of information about plasma catechol-
amine levels in both studies only allows speculation.
The differences in the protocols can probably explain
some of the differences measured in both studies. With
the present protocol, we tried to reflect better what
happens during a real ascent, i.e., meals taken in
progressively increasing hypoxia.
Several in vitro and animal models have shown de-
creased muscle protein synthesis in hypoxia (11, 49–
51). One study reported decreased mTOR protein
content after 7–9 d of exposure to 4559 m, but no
change in eukaryotic translation initiation factor 2
(eIF2) was observed (52). Furthermore, acute hypo-
baric hypoxia has been shown to slow protein synthesis
in the forearm muscle compartment (estimated by
leucine uptake; ref. 53) and a blunted exercise-induced
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increase in muscle protein synthesis after 3.5 h in
normobaric hypoxia (12% inspired O2) has been found
(54). Conversely, in another study, the myofibrillar
protein synthesis rate was doubled after 79 d of
exposure to 4559 m (55), and D’Hulst et al. (25) found
that markers of muscle protein synthesis (PKB and
S6K1) were activated after 4 h in normobaric hypoxia
(11% inspired O2). However, in the present study,
hypoxia did not alter the phosphorylation state of
markers of protein synthesis, i.e., PKB, S6K1, and
4E-BP1. Immediately after exercise, a decrease in the
phosphorylation state of those proteins was found in
both normoxia and hypoxia, with no differences be-
tween conditions. Those results indicate that exercise
was a more potent signal for regulating the PKB/
mTOR pathway than hypoxia in our conditions, prob-
ably by regulating plasma insulin concentration, be-
cause the decrease in the phosphorylation state of PKB,
S6K1, and 4E-BP1 paralleled the decrease in insulin
concentration after exercise.
REDD1 and AMPK do not inhibit the mTORC1
pathway
The fact that the PKB/mTOR pathway was not altered
by environmental hypoxia in our study is unexpected
for 2 reasons. First, environmental hypoxia caused a
drop in %SpO2 by 22%, which was accompanied by a
5% lower muscle TOI, indicating that hypoxia was
present at the muscle level. Second, 2 markers known
to be sensitive to hypoxia and to inhibit the mTORC1
pathway (32) were measured, i.e., REDD1 and AMPK.
Our data show that despite a large increase in REDD1
protein expression and AMPK phosphorylation after
acute exposure to environmental hypoxia, no inhibi-
tory effect on the PKB/mTOR pathway was observed.
Whereas the regulation of REDD1 by exercise has only
been poorly studied, it was quite surprising to observe
that AMPK was not modified by our exercise protocol
either in normoxia or in hypoxia. The relative exercise
intensity in normoxia (50% Vo2max) was low, which
probably explains why AMPK phosphorylation was not
altered. However, in hypoxia, the relative intensity
corresponded to 80% Vo2max and should have elic-
ited a higher phosphorylation state (56). It is therefore
possible that our exercise protocol was not long
enough to allow AMPK to be further phosphorylated
compared with that under resting conditions in hyp-
oxia because both intensity and duration determine the
activation of AMPK (57). REDD1 and AMPK did not
modify the phosphorylation of the PKB/mTOR path-
way, nor was this the case for another potential inhibi-
tor of this pathway, i.e., MSTN. MSTN, a member of the
transforming growth factor- family, acts as a negative
regulator of skeletal muscle mass, presumably through
down-regulation of the PKB/mTOR pathway (58), and
it has also been shown to partly account for the
hypoxia-induced wasting of muscle mass (59). How-
ever, neither hypoxia nor exercise modified the mRNA
expression of myostatin in our study.
MZ similarity in the molecular response to hypoxia
and exercise
Physiological adaptations to hypoxia vary widely among
individuals (10). In the present study, we found large
interindividual variability for the drop in %SpO2 in
hypoxia ranging from 15 to 32% at rest and from 20 to
35% after exercise. It has been suggested that genetic
factors could be partially responsible for the variability
in these adaptations (10). Up to now, a few genetic
variants have been found to influence the physiological
adaptations to hypoxia, such as variants in the angio-
tensin-converting enzyme, nitric oxide 3, peroxisome
proliferator-activated receptor , or heat shock protein
70 genes (10). However, none of those genes is in-
volved in the regulation of protein metabolism, and, at
this time, it is not known whether genetic factors
influence the regulation of muscle protein balance by
hypoxia. Using an MZ twin design in the present study,
we were able to partially answer this question, although
the sample size was rather limited. Therefore, the
threshold for significant ICCs was set at 0.75. Despite
this limitation, large interindividual variability was
found for some protein and mRNA expressions in
response to hypoxia and/or exercise. However, those
adaptations were not randomly distributed among sub-
jects. A high MZ twin resemblance was found for the
change in REDD1 and LC3-II protein expressions in
response to hypoxia at rest and for the change in
REDD1 in response to hypoxia after exercise, indicat-
ing that, if other common environmental factors are
lacking, genetic factors are involved in those responses.
REDD1 did not inhibit the mTORC1 pathway in the
present study; therefore, its increase is of minor physi-
ological significance, at least in the regulation of pro-
tein metabolism. On the contrary, the increase in
LC3-II is an important initial step in the activation of
autophagy together with the decrease in p62/SQSTM1,
and we show here that the hypoxia-induced increase in
LC3-II partially depends on genetic factors. To the best
of our knowledge, this is the first study to demonstrate
that the effect of hypoxia on molecular adaptations is
familial and most likely genetically determined. We
have to acknowledge that a limitation of the present
study is that dizygotic twins were not included in the
experimental design, which would have allowed dis-
crimination between similarity-inducing factors of ge-
netic and shared (common) environmental factors.
The MZ twin exposure design has, however, been
applied frequently by other groups to study genotype
environment interactions (31) and was earlier com-
pared with a longitudinal design including MZ and
dizygotic twins in a genotype  strength training inter-
action study (60), leading to similar interpretations. We
therefore acknowledge that the reported twin resem-
blances reflect upper-limit heritabilities and the F tests
indicate an upper-limit estimation of genotype  HYP
interaction because the contribution of shared/com-
mon environmental effects could not be tested.
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Further perspectives
Protein turnover is not only determined by protein
synthesis and degradation but also by cell turnover,
namely the addition of new myonuclei through satellite
cell fusions and the loss of myonuclei through nuclear
apoptosis (61). Satellite cells have been shown to
become activated in vivo during muscle regeneration
(62) and functional overload (63). Some in vitro models
have also shown that hypoxia promotes satellite cell
proliferation (64, 65). However, whether hypoxia acti-
vates satellite cells in vivo has not been investigated yet.
Because PCNA has been shown to be a marker of
satellite cell activation (37), we measured its mRNA
level. For the first time, we show that in human skeletal
muscle, PCNA mRNA expression was increased after
exercise in hypoxia, with a substantial similarity within
MZ pairs. Although we did not determine other mark-
ers because this was beyond the scope of the present
study, further research to look at the regulation of
satellite cell proliferation and/or activation by hypoxia
alone or in combination with exercise might be prom-
ising. The moderate to high MZ similarities in LC3-II,
REDD1, and PCNA responses merit further investiga-
tion into specific variants within these genes or other
regulatory genes that might partially predict a higher
sensitivity to muscle wasting in hypoxia-related condi-
tions.
CONCLUSIONS
Our results indicate that environmental hypoxia modu-
lates protein metabolism at rest and after moderate exer-
cise by primarily altering markers of protein breakdown
and more specifically markers of the autophagy-lysosomal
system in human skeletal muscle. In addition, we show for
the first time that some of those cellular adaptations to
hypoxia alone or in combination with exercise depend on
familial and most likely genetic factors, even though to a
modest extent. Although protein breakdown was not
directly assessed, our results suggest that the up-regulation
of catabolic pathways could induce muscle atrophy during
chronic hypoxia.
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